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Abstract 14 
The ability of NO to induce biofilm dispersion has been well established. Here we investigated 15 
the effect of nitroxides (sterically hindered nitric oxide analogues) on biofilm formation and 16 
swarming motility in Pseudomonas aeruginosa. A transposon mutant unable to produce nitric 17 
oxide endogenously (nirS) was deficient in swarming motility relative to wild type and the 18 
complemented strain. Moreover, expression of the nirS gene was up-regulated by 9.65-fold in 19 
wild type swarming cells when compared to planktonic cells. Wild type swarming levels were 20 
substantially restored upon exogenous addition of nitroxide containing compounds, consistent 21 
with the hypothesis that NO is necessary for swarming motility. Here, we showed that nitroxides 22 
not only mimicked the dispersal activity of NO, but also prevented biofilms from forming in 23 
flow cell chambers. In addition, a nirS transposon mutant was deficient in biofilm formation 24 
relative to wild type and the complemented strain, thus implicating NO in the formation of 25 
biofilms. Intriguingly despite its stand alone action in inhibiting biofilm formation and 26 
promoting dispersal, a nitroxide partially restored the ability of a nirS mutant to form biofilms. 27 
28 
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INTRODUCTION 29 
Bacteria are able to develop multicellular growth states such as swarming motility and biofilms 30 
(1, 2, 3). Swarming motility is a distinct growth state representing a complex multicellular 31 
adaptation to semi-solid (viscous) surfaces. It is widespread among flagellated bacteria, 32 
including Pseudomonas aeruginosa Salmonella, Vibrio, Yersinia, Serratia and Proteus (4). 33 
During swarming, cells move in a highly coordinated manner [e.g. giving a dendritic colonial 34 
appearance in P. aeruginosa PA14 (4, 5, 6)] that is dependent on hundreds of genes, including 35 
many regulators, and exhibits the differential expression of many genes (4, 6) leading to 36 
increased antibiotic resistance and altered metabolism and increased virulence factor expression 37 
(2, 4, 6). 38 
Biofilms are structured, surface-associated microbial communities that are highly resistant to 39 
antibiotics (3, 5, 7). Biofilms are formed as a result of a complex developmental life cycle that 40 
often includes the coordinated dispersal of biofilm cells from the mature biofilm and 41 
differentiation into planktonic cells, presumably to enable new biofilm colonies to form 42 
elsewhere (1, 3, 8).  43 
Here, we focused on the bacterial pathogen Pseudomonas aeruginosa as it is a model for the 44 
study of swarming motility and biofilms (5). P. aeruginosa is a Gram negative opportunistic 45 
bacterium that is the leading cause of nosocomial and chronic lung infections in cystic fibrosis 46 
(CF) patients (5). CF is the most common inherited lethal disorder of Caucasian populations. P. 47 
aeruginosa biofilms have been found in the infected lungs of individuals with CF and are 48 
thought to contribute to their persistent phenotype (3, 5, 9). Both biofilm formation leading to 49 
microcolonies in the CF lung and swarming motility in the context of the viscous mucoid 50 
environment of the CF lung are thought to be important in influencing colonization and 51 
persistence.  52 
Biofilm dispersal can be induced by a variety of small molecules, including nitric oxide (NO) 53 
(10, 11). NO is a signaling molecule involved in many biological processes (12). Interestingly, 54 
NO produced by bacterial nitric oxide synthases has been shown to increase the resistance of 55 
bacteria to a broad spectrum of antibiotics through the chemical medication of toxic compounds 56 
and reduction of antibiotic-induced oxidative stress (13, 14). Previous reports identified and 57 
described the role of NO in the regulation of dispersal in P. aeruginosa biofilms (10, 11, 15). NO 58 
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has also been shown to be related to anaerobic metabolism in the context of biofilm survival and 59 
dispersal (15, 16). The dispersal of biofilms to free swimming planktonic bacteria occurs at low 60 
non-toxic concentrations of NO in a variety of Gram positive and Gram negative bacterial 61 
species (8, 10). Furthermore, several studies have reported a link between NO and turnover of the 62 
second messenger c-di-GMP, indicating that a decrease in the levels of c-di-GMP results in a 63 
switch to dispersal and the planktonic mode of existence (17, 18). In P. aeruginosa, NO is 64 
synthesized by the enzyme nitrite reductase encoded by the gene nirS (Fig. 1) (10). To limit 65 
toxicity, NO is then reduced to nitrous oxide by a nitric oxide reductase (norBC) (Fig. 1) (10). 66 
Nitroxides (or aminoxyls) are long-lived free radical species consisting of a disubstituted 67 
nitrogen atom bound to a univalent oxygen atom (19). Their stability arises because of the high 68 
delocalisation energy of the unpaired electron over both the nitrogen and oxygen atoms, making 69 
them resistant to dimerisation. They are also resistant to degradation through disproportionation 70 
when the carbon atoms adjacent to the nitroxide centre are substituted with bis (tert-alkyl) groups 71 
(20). As both nitric oxide and nitroxide structures possess an unpaired electron which is 72 
delocalised over the nitrogen-oxygen bond, nitroxides represent a sterically hindered version of 73 
nitric oxide. These stable free-radical species are commonly used as potent antioxidants in 74 
biological systems (21, 22). Like NO, these compounds can reduce levels of oxidative stress 75 
caused by reactive oxygen species (ROS). Many of the biological effects of nitroxides can be 76 
explained by their nitric oxide-mimetic properties, with both compounds exerting superoxide 77 
dismutase mimetic properties. Nitroxides and nitric oxide are both efficient scavengers of 78 
protein-derived radicals (23).  79 
MATERIALS AND METHODS  80 
Strains and Media 81 
Stains utilized included a wild type bacterium P. aeruginosa PA14 and two mutants from the 82 
transposon-MAR2xT7 Harvard library (24), namely nirS and norS. To complement the nirS 83 
mutation we cloned the gene as follows. First the nirS gene was amplified from strain PA14 84 
using primers 0519F: CCACAAGCGCAAAGCAACG and 0519R: 85 
TCGATGGCATGGCAGGCC, and the 2 kb amplified DNA fragment containing the nirS gene 86 
subsequently cloned into a pUC18T mini Tn7T-Tet plasmid (pUC18T mini Tn7T-Tet-nirS+). 87 
The insertion of the transposon carrying gene nirS in a single attTn7 site within the chromosome 88 
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of P. aeruginosa was done according to the protocol described by Choi and Schweizer (25). 89 
Briefly, the plasmid pUC18T mini Tn7T-Tet-nirS+ was co-electroporated with the plasmid 90 
helper pTNS2 in nirS mutant electrocompetent cells. Positives clones containing the 91 
complementation were selected on LB plus 50 µg/ml of tetracycline. The insertions were 92 
confirmed by PCR using primers PTn7-up and PglmS-down as previously described (25). Strains 93 
were maintained and routinely grown on Luria Broth medium and plates.  94 
Nitroxides. Carboxy-TEMPO (4-carboxy-2,2,6,6-tetramethylpiperidine 1-oxyl, Fig. 2) was 95 
obtained commercially (382000, Sigma Aldrich). CTMIO (5-carboxy-1,1,3,3-96 
tetramethylisoindolin-2-yloxyl, Fig. 2) (26, 27) and DCTEIO (5,6-dicarboxy-1,1,3,3-97 
tetraethylisoindolin-2-yloxyl, Fig. 2) were prepared using previously described methods (28). 98 
Growth curves. PA14 wt and nirS mutant strains were grown overnight in BM2 swarming 99 
medium (62 mM potassium phosphate buffer [pH 7], 2 mM MgSO4, 10 µM FeSO4, 0.4% 100 
[wt/vol] glucose, 0.1% [wt/vol] Casamino Acids). Cultures were diluted to obtain equal optical 101 
densities. Five-microliter portions of these cultures were added to 195 µl of fresh swarming 102 
medium in 96-well microtiter plates. The growth of these cultures at 37°C under shaking 103 
conditions was monitored with a TECAN Spectrofluor Plus by determining the absorbance at 104 
620nm every 20 min for 28 hr.  105 
Swarming motility assays. Swarming assays were performed as previously described (4, 29) on 106 
BM2 swarming agar plates (62 mM potassium phosphate buffer [pH 7], 2 mM MgSO4, 10 µM 107 
FeSO4, 0.4% [wt/vol] glucose, 0.1% [wt/vol] Casamino Acids, 0.5% [wt/vol] Difco agar) in the 108 
absence or presence of different concentrations of the nitroxide derivatives. One-l aliquots of 109 
mid-log-phase (i.e., OD600 of 0.4 to 0.6) cultures grown in BM2 minimal medium [62 mM 110 
potassium phosphate buffer (pH 7), 7 mM (NH4)2SO4, 2 mM MgSO4, 10uM FeSO4, 0.4% 111 
(wt/vol) glucose supplemented with 0.1% [wt/vol] casamino acids] were inoculated on Petri dish 112 
plates. Each experiment was carried out at least three times. All resulting dendritic colonies were 113 
analyzed by measuring the surface coverage on agar plates after 20 h of incubation at 37°C using 114 
Image J software and represented as % of wild-type. 115 
RT-qPCR assays. Reverse transcription quantitative polymerase chain reaction (RT-qPCR) was 116 
performed to examine the expression of genes nirS, norB and norC under swarming conditions 117 
as opposed to planktonic growth. Actively swarming cells from the edges of swarming colonies 118 
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were harvested. For planktonic growth assays, mid-logarithmic-phase cells (OD600: 0.4) grown in 119 
liquid cultures were isolated prior to RNA extraction. For RNA extraction, RNeasy mini 120 
columns (QIAGEN, Mississauga, ON, Canada) were used and total RNA was isolated from 121 
swarming cells and mid-log-phase P. aeruginosa PA14 cultures. RNA samples were treated with 122 
DNase I to remove contaminating genomic DNA. 750 nanograms of total RNA was added to a 123 
reaction mixture containing each deoxynucleoside triphosphate at a concentration of 0.5 µM, 500 124 
U/ml SuperaseIN (Ambion, Austin, TX), and 10 µM dithiothreitol in 1× reaction buffer and 125 
reverse transcribed for 1 h at 37°C and for 2 h at 42°C with 10,000 U/mL Superscript II reverse 126 
transcriptase (Invitrogen, Carlsbad, CA). The resulting cDNA was used as a template for PCR. 127 
The number of cycles used to amplify each gene of interest was chosen to ensure that the PCR 128 
was not saturated. All reactions were normalized to the rpsL gene encoding the 30S ribosomal 129 
protein S12. 130 
Biofilm flow cell assays. Biofilms were grown for 72 h, in the absence or presence of 20 µM of 131 
the nitroxide compounds, at 37°C in flow chambers with channel dimensions of 1 by 4 by 40 132 
mm. Silicone tubing (VWR, 0.062 in ID by 0.125 in OD by 0.032 in wall) was autoclaved, and 133 
the system was assembled and sterilized by pumping a 0.5% hypochlorite solution through the 134 
system at 6 rpm for 30 min using a Watson Marlow 205S multi-channel peristaltic pump. The 135 
system was then rinsed at 6 rpm with sterile water and medium for 30 min each. Flow chambers 136 
were inoculated by injecting 400 µL of an overnight culture diluted to an OD600 of 0.05. After 137 
inoculation, chambers were left without flow for 2 h, after which medium was pumped through 138 
the system at a constant rate of 0.75 rpm (3.6 mL/h). Biofilm cells were stained using the 139 
LIVE/DEAD BacLight Bacterial Viability kit (Molecular Probes, Eugene, OR) prior to 140 
microscopy experiments. A ratio of SYTO-9 (green fluorescence, live cells) to propidium iodide 141 
(PI) (red fluorescence, dead cells) of 1:5 was used. Microscopy was done using a confocal laser 142 
scanning microscope (Olympus, Fluoview FV1000) and three-dimensional reconstructions were 143 
generated using the Imaris software package (Bitplane AG). 144 
Biofilm dispersal flow cell assays. P. aeruginosa biofilms were grown as indicated above for 48 145 
hr in the absence of nitroxides. After this time, biofilms were exposed to 20 µM of the nitroxide 146 
compounds for 24 hr to assess their ability to disperse pre-formed biofilms. For this, nitroxides 147 
were added to the medium and pumped through the flow cells as described above. Staining and 148 
visualization of the resulting biofilms was performed using the LIVE/DEAD BacLight Bacterial 149 
6 
 
Viability kit (Molecular Probes, Eugene, OR) and a confocal laser scanning microscope 150 
(Olympus, Fluoview FV1000) as previously described. 151 
MIC assays. Briefly, the nitroxides were dissolved in water, and MIC assays were performed 152 
using CLSI broth microdilution method (29, 30) in sterile 96-well polypropylene microtiter 153 
plates (catalog no. 3790; COSTAR). Nitroxides were added to the plate at the desired 154 
concentrations, and the bacteria were inoculated at a final concentration of 5×105 CFU/ml per 155 
well. The plates were incubated at 37°C for 24h. The MIC was defined as the lowest 156 
concentration of peptide at which no growth was observed. 157 
 158 
RESULTS AND DISCUSSION 159 
Effect of a nirS mutation on swarming motility; genetic and chemical complementation. To 160 
examine the role of endogenous NO on multicellular bacterial behaviors, we tested the ability of 161 
a strain PA14 nirS transposon mutant (24) to undergo swarming motility. The nirS mutant was 162 
considerably less able to swarm demonstrating a 76% decrease in surface coverage (Fig. 3B). In 163 
contrast a norB mutant, deficient in the ability to reduce NO to nitrous oxide, showed no defect 164 
in swarming. Genetic complementation of the nirS mutant with the nirS gene fully restored 165 
swarming (Fig. 3B), thus confirming that nirS was responsible for the observed deficiency. 166 
Importantly, planktonic growth of the nirS mutant was indistinguishable from that of the wild-167 
type strain (Fig. 3A), thus minimizing the possibility that the deficiency in swarming may have 168 
been due to a growth-deficiency. 169 
In an attempt to chemically complement the deficiencies in the switch to multicellularity 170 
observed in the nirS mutant, we investigated the use of water-soluble nitroxides. First, we 171 
determined the direct antimicrobial activity of compounds carboxy-TEMPO, CTMIO and 172 
DCTEIO as NO is known to exhibit direct antimicrobial activity at high concentrations (31). An 173 
MIC>160 µM was obtained for all three compounds using the broth microdilution method. 174 
Growth curve experiments further revealed that sub-lethal levels of nitroxide derivatives (20 175 
µM) did not affect planktonic growth of mutants nirS and norB mutants (data not shown).  176 
The effect of sub-lethal levels of the nitroxides on swarming by strains PA14 wild-type and its 177 
nirS mutant were then tested. All experiments were performed at least three times. The nitroxides 178 
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by themselves did not affect the swarming motility of the wild-type, but exogenous addition of 179 
20 µM of each of the nitroxides complemented the swarming phenotype to various extents (Fig. 180 
3C). The more hydrophobic derivatives DCTEIO (90.6%) and CTMIO (89.1%) were more 181 
efficient at restoring the swarming ability of a nirS mutant to near wild type levels when 182 
compared to the more hydrophilic compound carboxy-TEMPO (62.1%). Moreover, the 183 
complementation exerted by exogenous treatment with the nitroxides appeared to be 184 
concentration-dependent. Indeed, while 0.2 µM of the compounds enhanced dendrite formation, 185 
this effect was increased when using 2 µM nitroxides (data not shown). Higher concentrations of 186 
nitroxide analogs (20 µM) complemented the swarming phenotype (Fig. 3C). Therefore, the 187 
nitroxides appeared to complement the swarming-deficiency that was apparently caused by a 188 
lack of endogenous NO, implying that these compounds maintained some properties of 189 
endogenous NO.  190 
The expression of genes nirS, norB and norC under swarming conditions, as opposed to 191 
planktonic growth, was tested by RT-qPCR. Consistent with its role in swarming motility, the 192 
nirS gene was 9.65 ± 0.16 fold more highly expressed in wild-type strain PA14 swarming cells 193 
compared to the same strain when grown under planktonic conditions. Conversely, norB and 194 
norC were not found to be differentially expressed in these experiments. Neither nirS nor norB 195 
(PA14 transposon mutants) (24) were altered in growth (when compared to the PA14wt strain) in 196 
LB or BM2 media with or without Casamino Acids (data not shown), thus suggesting that 197 
endogenous NO synthesis is not essential for normal planktonic growth. From these 198 
observations, we concluded that endogenously-produced NO was required for normal swarming 199 
motility but not for planktonic growth.  200 
Effect of a nirS mutation on Biofilm Formation. The nirS mutant was unable to form biofilms 201 
when grown in flow cell chambers, in contrast to the wild-type PA14, the genetically 202 
complemented strain and the norB mutant (Fig. 4A). Indeed, PA14 wt biofilms were 28.6 µm 203 
thick, while the unstructured monolayer of cells formed by the nirS mutant was only 6.7 µm in 204 
thickness. On the other hand, biofilms formed by norB showed similar thickness to the wild-type 205 
(22.7 µm). Unlike the nirS mutant, the nirS genetically-complemented strain formed structured 206 
biofilms in the flow cell assay (thickness= 16.7 µM), thus suggesting that the biofilm-deficiency 207 
of the nirS mutant was due to the mutation in the gene nirS. All thickness values were calculated 208 
based on the 20 µm scale present in all biofilm images. This indicates that NO might have 209 
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another role in biofilm formation other than the known role in biofilm dispersal (10), since an 210 
inability to make NO strongly inhibited biofilm formation. It is possible that these different 211 
effects would be related to the concentration of NO in the cell and the differentiation stage of the 212 
cells. The inability of the nirS mutant to form biofilms and the role of NO in biofilm dispersion 213 
may at first seem contradictory. However, the processes involved in the initial and dispersal 214 
stages of biofilm development are distinct. For example, type IV pili-mediated twitching motility 215 
allows early microcolony formation (1, 3, 32) and is therefore essential for the eventual 216 
development of fully mature biofilms. However, over-stimulation of twitching motility leads to 217 
detachment of cells from biofilms (33). Furthermore, results recently reported (34) describing the 218 
ability of NO to stimulate biofilm formation by controlling c-di-GMP levels are in agreement 219 
with the biofilm-deficiency of nirS mutant presented here. 220 
Since mutant strain nirS was deficient in biofilm formation, we hypothesized that the 221 
nitroxides might be able to complement the deficient phenotype. We grew the nirS mutant in 222 
flow cell chambers in the presence of the nitroxides and observed increased cell aggregation 223 
(biofilm thickness = 9.3 µm) after 3 days with carboxy-TEMPO addition (Fig. 4A), and 224 
structured cell aggregates when adding DCTEIO (Fig. 4A). However, no major biofilm 225 
structures comparable to the ones formed by wild-type PA14 were identified in these samples. In 226 
conclusion, the nitroxide derivatives were able to only partially complement the biofilm-deficient 227 
phenotype of nirS. We argue that the phenotype is only partially rescued due to the absence of 228 
NO in the nirS mutant strain. TEMPO and DCTEIO when added presumably acted as a surrogate 229 
for NO in the cell but did not fully complement NO absence. 230 
To investigate the basis for this limited chemical complementation, cf. the case for swarming 231 
motility, we examined the effect of the nitroxide analogs on P. aeruginosa biofilms. When wild-232 
type strain PA14 was grown in flow cells for 3 days in the presence of 20 µM of the nitroxides, 233 
biofilms were unable to develop (Fig. 4B) consistent with the conclusion that these compounds 234 
were able to inhibit the initial stages of biofilm formation. In addition, treatment with the analogs 235 
triggered the dispersal of 2-day-old pre-formed PA14 biofilms (Fig. 4B). In fact, nitroxide-236 
induced dispersion led to biofilm dissolution with only a thin monolayer of cells (thickness = 4 237 
µm) attached to the flow cell chamber. From these results we infer that addition of nitroxides to 238 
an otherwise NO-producing strain (PA14 wt) had the same impact as excess levels of NO which 239 
increases the biofilm dispersal processes. 240 
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Nitroxide-induced biofilm dispersal did not involve cell death as there was no observable 241 
increase in dead cells (revealed by a lack of staining with red propidium iodide). Both the 242 
inhibition of initial biofilm formation and the dispersal of mature biofilms may be explained by 243 
the presumptive biofilm dispersal properties of the nitroxide derivatives. In other words, newly-244 
differentiated biofilm cells may be readily dispersed by the compounds both at the beginning of 245 
biofilm development and during the final dispersal events. The well-established ability of NO to 246 
disperse biofilms was therefore conserved in the different analogs.  247 
The gene encoding for enzyme nitrite reductase nirS was essential for swarming and biofilm 248 
formation as shown by phenotypic characterization assays. Indeed, up-regulation of nirS was 249 
observed in swarming but not planktonic cells. However, biosynthesis of endogenous NO did not 250 
appear to contribute to planktonic growth as the nirS mutant displayed growth dynamics 251 
identical to the wild-type strain. As endogenous NO is known to increase resistance to 252 
antibiotics, we propose that the production of this molecule may be in part responsible for the 253 
antibiotic-resistant phenotypes observed in swarming and biofilm cells. Overall, the inability of 254 
nirS transposon mutant to swarm or form biofilms appeared to be due to its lack of endogenous 255 
NO biosynthesis as synthetic NO analogs were able to at least partially complement both 256 
phenotypes. Moreover, treatment of PA14 biofilms with nitroxides led to inhibition of biofilm 257 
development and triggered biofilm dispersion, possibly due to excess NO levels. We therefore 258 
hypothesize that the concentration of intracellular NO (and/or NO-like molecules) is critical to 259 
either trigger or repress biofilm formation. These studies have revealed new features of 260 
multicellular behavior in Pseudomonas aeruginosa and underline the potential of nitroxides as 261 
agents that can inhibit biofilm formation and trigger biofilm dispersal. 262 
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Figures 363 
 364 
Figure 1. Nitric oxide metabolism in P. aeruginosa. 365 
 366 
Figure 2. Structures of the nitroxide compounds.  367 
 368 
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Figure 3. Involvement of NO in swarming motility. A. A nirS mutant was not growth-deficient 370 
when compared to its parent strain PA14. B. A nirS mutant, but not the complemented strain or a 371 
norB mutant, was deficient in swarming motility. C. Chemical complementation of the nirS 372 
mutant swarming-deficiency by subinhibitory levels (20 µM, the minimum concentration of 373 
nitroxides that almost fully complemented the swarming phenotype) of nitroxides. 374 
Representative images are shown of at least three independent swarming experiments performed 375 
per condition. Average percentage (%) surface area values are relative to wild-type swarming in 376 
all cases. Shown in parenthesis are t-tests performed to assess significance levels (where ns 377 
p>0.05, * p<0.05, ** p<0.01, and *** p<0.001). In B) t-test analyses were used to compare the 378 
surface area values of swarming colonies of mutants nirS and norB and the complemented PA14 379 
nirS strain to PA14 wt. In the upper panel of C), the statistical significance of PA14 wt swarming 380 
in the presence of nitroxides was compared to swarming of PA14 wt alone. Significant P values 381 
shown on the lower panel of C) represent swarming of mutant nirS treated with nitroxide 382 
compounds relative to nirS untreated. 383 
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Figure 4. Effect of nirS on biofilm development and the biofilm inhibitory activity of 398 
nitroxide compounds. A. Biofilms were cultivated in minimal medium for 3 days at 37°C in 399 
flow cell chambers and stained with SYTO-9 (green; live cells) and propidium iodide (PI) (red; 400 
dead cells). No increase in dead cells was observed in nirS and norB mutants when compared to 401 
PA14 wt biofilms. Exogenous addition of 20 µM of the nitroxide derivatives carboxy-TEMPO 402 
and DCTEIO partially complemented nirS mutant biofilm formation in flow cells. B. Low levels 403 
of nitroxide compounds (20 µM) prevented initial biofilm formation in flow cells (b) and 404 
triggered biofilm dispersal (c). Biofilms were visualized using SYTO-9 to stain live cells green 405 
and propidium iodide (PI) to stain dead cells red. All samples were then examined using CLSM. 406 
The scale bar represents 20 µm in length, and each panel shows xy, yz, and xz dimensions.   407 
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